¿Cómo se comparó el EPS reciente de GWLL con las expectativas?
¿Cómo fue el desempeño de los ingresos de Goldenwell Biotech Inc GWLL en el último trimestre?
¿Cuál es la estimación de ingresos para Goldenwell Biotech Inc?
¿Cuál es la puntuación de calidad de ganancias de Goldenwell Biotech Inc?
¿Cuándo informa Goldenwell Biotech Inc sus ganancias?
¿Cuáles son las ganancias esperadas de Goldenwell Biotech Inc?
¿Superó Goldenwell Biotech Inc las expectativas de ganancias?
Estadísticas clave
Cierre Anterior
$1.05
Precio de apertura
$1.05
Rango del día
$1.05 - $1.05
Rango de 52 semanas
$0.2 - $10
Volumen
500
Volumen promedio
97
EPS (TTM)
-0.00
Rendimiento de dividendos
--
Cap. de mercado
$103.9M
¿Qué es GWLL?
Goldenwell Biotech, Inc. is a development stage company, which engages in the research & development and industrialization of healthcare products, bio-pharmaceuticals and bio-engineering drugs, and food and cosmetics products. The company is headquartered in Solon, Ohio. The company went IPO on 2021-12-07. The firm is offering its products under two categories: Polypeptide Freeze-dried Powder and Solid Tablets Products. The Company’s products are JI MAI-Bovine Cardiac Vascular Active Peptide, Double Proline AG- three-dimensional (3D) Active Collagen Peptide, Cartilage Peptide-Type II collagen peptide, Se Plus, and Sugar Master. Bovine cardiac vascular active peptide is a protein peptide of vascular homology (amino acid type and its sequence) which made from healthy and fresh bovine cardiac vascular tissues as raw materials. Its DPAG product is designed to be an easily absorbed bioactive collagen. Type II collagen peptide is prepared from Bovine or Pig Cartilage bones by hot water extraction. Its Sugar Master product is made utilizing low temperature extraction techniques to maximize the harvest of bio-actives of plant matter.